NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

austinmediainc,

The one year time frame for regulatory resolution of certain matters is not set in stone but several types of responses from regulators are often answered within this time frame though some can go longer. There are also multiple primary estimated completion dates timed for September from NWBO trials. This is a clue as to what NWBO had in mind for converging various sources of information. Let's not forget that 2 year survival from Phase 1 Direct is coming up soon as well. Regulators get active again after summer breaks and significant news often comes out of meetings in September as well as early in calender years after the fall and winter holidays.

As to your question about ongoing submissions, that was confirmed in the 5-2-2016 operations updates press release. "The company is in ongoing dialog with regulators, and providing further information." I worded this as "ongoing submissions" which may have tripped a key word trigger that you responded to since the word submission is so often used with a BLA or other type of formal petition to regulators.

As far as the news release about their internal and external investigations maybe, just maybe there is something much bigger going on behind the scenes and so they wait out both investigations perhaps at the behest of investigators. Could it be possible that the recent changes in law towards states rights might be the impetus for bringing a case against protagonists of small biotechs? Could NWBO be a prime candidate as a lead plaintiff in a federal fraud case? We can question Linda's motives all we want just like we can wonder who has a vested interest in NWBO and who does not on this board. The bottom line is that motives are best determined by final outcome so we theorize now and wait for results. Some will be proven more right than others with what eventually happens so we wait. Best wishes.